溫氏股份(300498.SZ):4月生豬銷售收入55.45億元
格隆匯5月7日丨溫氏股份(300498.SZ)公佈,2025年4月銷售肉雞10,381.98萬隻(含毛雞、鮮品和熟食),收入25.43億元,毛雞銷售均價11.24元/公斤,環比變動分別爲-0.87%、0.91%、3.21%,同比變動分別爲10.87%、-5.01%、-14.91%。
公司2025年4月銷售生豬317.57萬頭(其中毛豬和鮮品共289.99萬頭,仔豬27.58萬頭),收入55.45億元,毛豬銷售均價14.92元/公斤,環比變動分別爲2.59%、1.91%、0.34%,同比變動分別爲27.90%、18.61%、-1.71%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.